Literature DB >> 19389638

The seizuring cat. Diagnostic work-up and therapy.

Kerry Smith Bailey1, Curtis W Dewey.   

Abstract

PRACTICAL RELEVANCE: Although seizures occur less commonly in cats compared with dogs, they are one of the most common forms of neurological disease in the feline patient. Cats may experience both focal (partial) and generalized seizures and causes are divided into primary disorders, in which there is no underlying cause (ie, idiopathic epilepsy), and secondary disorders. Cats with secondary seizure disorders have either an underlying structural lesion or metabolic disease. PATIENT GROUP: Seizures affect cats of all ages. Cats with idiopathic epilepsy tend to be younger (approximately 3.5 years) than cats with secondary seizure disorders (approximately 8 years). AUDIENCE: This review of feline seizures is directed at all veterinarians who treat cats, both in an emergency setting as well as in general practice. CLINICAL CHALLENGES: Refractory seizures are often a diagnostic and therapeutic challenge. A systematic approach to the seizuring cat is described, easing the task of diagnosing the cause of the seizures. In addition, novel antiepileptics are discussed, which can be used as add-on drugs in challenging feline seizure cases. EVIDENCE BASE: Compared with the canine counterpart, the literature regarding treatment of feline seizures is less established. Recent clinical trials and studies are focusing on new treatment options for feline seizures. Specifically, these studies, some of which are ongoing, have led to the use of levetiracetam, zonisamide and pregabalin as add-on antiepileptics in cases that are refractory to phenobarbital.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389638     DOI: 10.1016/j.jfms.2009.03.006

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  7 in total

Review 1.  LGI Proteins and Epilepsy in Human and Animals.

Authors:  A Pakozdy; M Patzl; L Zimmermann; T S Jokinen; U Glantschnigg; A Kelemen; D Hasegawa
Journal:  J Vet Intern Med       Date:  2015-06-01       Impact factor: 3.333

2.  Imepitoin is well tolerated in healthy and epileptic cats.

Authors:  Odilo Engel; Thilo von Klopmann; Arianna Maiolini; Jessica Freundt-Revilla; Andrea Tipold
Journal:  BMC Vet Res       Date:  2017-06-12       Impact factor: 2.741

3.  Systematic review of antiepileptic drugs' safety and effectiveness in feline epilepsy.

Authors:  Marios Charalambous; Akos Pakozdy; Sofie F M Bhatti; Holger A Volk
Journal:  BMC Vet Res       Date:  2018-03-02       Impact factor: 2.741

4.  Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats.

Authors:  Heidi Barnes Heller; Martin Granick; Mathew Van Hesteren; Dawn M Boothe
Journal:  J Vet Intern Med       Date:  2018-04-19       Impact factor: 3.333

5.  Feline orofacial pain syndrome (FOPS): a retrospective study of 113 cases.

Authors:  Clare Rusbridge; Sarah Heath; Danièlle A Gunn-Moore; Susan Penelope Knowler; Norman Johnston; Angus Kennedy McFadyen
Journal:  J Feline Med Surg       Date:  2010-05-06       Impact factor: 2.015

Review 6.  Epilepsy in cats: theory and practice.

Authors:  A Pakozdy; P Halasz; A Klang
Journal:  J Vet Intern Med       Date:  2014-01-17       Impact factor: 3.333

7.  Clinical characterization of epilepsy of unknown cause in cats.

Authors:  A M Wahle; A Brühschwein; K Matiasek; K Putschbach; E Wagner; R S Mueller; A Fischer
Journal:  J Vet Intern Med       Date:  2013-11-16       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.